These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15467033)

  • 1. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
    Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
    J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer.
    Ramus SJ; Elmasry K; Luo Z; Gammerman A; Lu K; Ayhan A; Singh N; McCluggage WG; Jacobs IJ; Whittaker JC; Gayther SA
    Clin Cancer Res; 2008 Sep; 14(18):5840-8. PubMed ID: 18794095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous endometrial and ovarian carcinomas: analysis of genetic relationship of the tumors.
    Nishimura N; Hachisuga T; Nabeshima K; Kawarabayashi T
    Int J Oncol; 2005 Dec; 27(6):1519-26. PubMed ID: 16273207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis.
    Huang J; Behrens C; Wistuba I; Gazdar AF; Jagirdar J
    Ann Diagn Pathol; 2001 Dec; 5(6):321-9. PubMed ID: 11745069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for common clonal origin of multifocal lung cancers.
    Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
    J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
    Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
    Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
    Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H
    Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
    Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping.
    Tse GM; Kung FY; Chan AB; Law BK; Chang AR; Lo KW
    Am J Clin Pathol; 2003 Aug; 120(2):168-74. PubMed ID: 12931545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
    Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.
    Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB
    Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple head and neck tumors: evidence for a common clonal origin.
    Bedi GC; Westra WH; Gabrielson E; Koch W; Sidransky D
    Cancer Res; 1996 Jun; 56(11):2484-7. PubMed ID: 8653681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease.
    Kupryjanczyk J; Thor AD; Beauchamp R; Poremba C; Scully RE; Yandell DW
    Mod Pathol; 1996 Mar; 9(3):166-73. PubMed ID: 8685209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker conservation in primary and metastatic epithelial ovarian cancer.
    Tewari KS; Kyshtoobayeva AS; Mehta RS; Yu IR; Burger RA; DiSaia PJ; Fruehauf JP
    Gynecol Oncol; 2000 Aug; 78(2):130-6. PubMed ID: 10926791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
    J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
    Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O
    Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence.
    Schlechter BL; Yang Q; Larson PS; Golubeva A; Blanchard RA; de las Morenas A; Rosenberg CL
    J Clin Oncol; 2004 May; 22(10):1830-8. PubMed ID: 15143075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.